Search

everythinglearnresearchcommunity

for

Search:↓

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Stress-related hair loss was reversed with a special medication.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

Glycyrrhizinic acid spray showed limited effectiveness in treating anogenital warts in HIV patients with low CD4 levels.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Monocytes might be linked to hair loss after COVID-19.

Targeting specific T cells may help treat alopecia areata.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Apremilast did not work for treating severe alopecia areata.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Fetal skin has unique immune cells different from adult skin.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Innate lymphoid cells type 1 may contribute to alopecia areata.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Yikgeebohyul-tang promotes hair growth and could help treat hair loss.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.